We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Private drug plans competing for business under the Medicare prescription drug benefit will be able to negotiate drug price savings that are at least equal to what the government could achieve through direct price negotiations, according to the head of the Centers for Medicare & Medicaid Services (CMS).